Theralink Precision Medicine of Life
Business Services · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15000 W 6th Ave Ste 400, Golden, Colorad...Phone Number
(888) 585-4923Website
www.theralink.comRevenue
<$5 MillionStock Symbol
THERIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Theralink Precision Medicine of Life
At Theralink Technologies, the company's approach is based on more than 16 years of research and development. The company's research indicates that genomic and transcriptomic information alone provides an incomplete information resource for physicians to make patient-specific treatment decisions.The company's phosphoproteomic RPPA approach is the only platform that quantifies the activation state (phosphorylation) of drug target proteins and their downstream signaling partners within the tumor tissue.The company's advanced technology exploits the company's understanding of the drug-receptor and drug-protein interactions that drive treatment responses. The Theralink assay has been developed to provide physicians with a treatment decision support tool to assist in selecting therapies that are more likely to result in responses to treatment.The company's large panel of new protein biomarkers targets therapeutic molecular inhibitors including current FDA approved therapies and certain inveRead more
Theralink Precision Medicine of Life Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Theralink Precision Medicine of Life your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Theralink Precision Medicine of Life launches new products
Earning: See what the market has to say on Theralink Precision Medicine of Life recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Theralink Precision Medicine of Life
Check if Theralink Precision Medicine of Life has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Theralink Precision Medicine of Life has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Theralink Precision Medicine of Life is spiking on competitors!
Click to see if Theralink Precision Medicine of Life had a recent Job posting/layoffs
Theralink Precision Medicine of Life, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Theralink Precision Medicine of Life as Masked Content
Find 2 more new buyers
Compare Similar Companies to Theralink Precision Medicine of Life
Compare insights from companies similar to Theralink Precision Medicine of Life, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Theralink Precision Medicine of Life is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Theralink Precision Medicine of Life is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Theralink Precision Medicine of Life.
Theralink Precision Medicine of Life financials insights
Gather financial insights about Theralink Precision Medicine of Life, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$11M
Theralink Precision Medicine of Life Tech Stack
A closer look at the technologies used by Theralink Precision Medicine of Life
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Promotion
Executive Move
Lateral Move
Executive Move
Theralink Precision Medicine of Life News & Media
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies (OTC: THER), a precision oncology company with an exclusively licensed commercial RPPA (reverse phase protein array) technology platform, is excited to announce groundbreaking work by George Mason University and the University of California, San Francisco, recently published in Cell Reports Medicine (https://linkinghub.elsevier.com/retrieve/pii/S2666379123005062). This incredible effort coming fromTheralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective in each cancer, today with its merger partner, IMAC Holdings, INC (Nasdaq: BACK), announce that the companies have responded to the SEC’s first round of comments on the jointly filed form S-4. A Form S-4Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Golden, Colorado, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective in each cancer, today announced that their long-standing, strategic partnership with the Inova Schar Cancer Institute (Inova) is beginning to deliver promising results by way of assessing the feasibility and impact of the actionTheralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
Golden, Colorado, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, today announces the filing of a Form S-4 with the Securities and Exchange Commission requisite to complete the previously announced merger between the Company and IMAC Holdings, Inc. (NASDAQ: BACK)(“IMAC”)(the “Merger”). Upon regulatory approval, Theralink and IMAC expect to compl
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Theralink Precision Medicine of Life
Sign Up For FreeTo access detailed company insights
At Theralink Technologies, the company's approach is based on more than 16 years of research and development. The company's research indicates that genomic and transcriptomic information alone provides an incomplete information resource for physicians to make patient-specific treatment decisions.The company's phosphoproteomic RPPA approach is the o... Read More
